Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.7050
+0.0350 (2.10%)
NASDAQ· Last Trade: Jun 15th, 12:27 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors